Commentary/Response Threads
-
Palmieri, C, Stein, RC, Liu, X, Hudson, E, Nicholas, H, Sasano, H, Guestini, F, Holcombe, C, Barrett, S, Kenny, L, Reed, S, Lim, A, Hayward, L, Howell, S and Coombes, RC
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. (deposited 23 Jan 2018 12:00)
- Palmieri, C, Stein, RC, Liu, X, Hudson, E, Nicholas, H, Sasano, H, Guestini, F, Holcombe, C, Barrett, S, Kenny, L, Reed, S, Lim, A, Hayward, L, Howell, S and Coombes, RC Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. (deposited 23 Jan 2018 12:12) [Currently Displayed]